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Aberrations of the p53 gene in 27 solar keratoses were 
examined by the polymerase chain reaction and sin-
gle-strand conformation polymorphism and DNA se-
quencing analyses. In a series of Japanese patients, 
eight of27 cases (30%) of solar keratosis showed struc-
tural abnormalities of the p53 gene. Six of eight 
aberrations of p53 gene were determined to be single 
nucleotide substitutions, and five of these were located 
at a dipyrimidine site. In solar keratosis, noticeable 
mutations were C to T in three cases, and one each of C 
M utations in the p53 gene from squamous cell car-cinoma (SCe) and basal cell carcinoma (BCe) were reported by Brash et ai, Pierceal et ai, and Moles et al [1- 3] in addition to mutations in the Ha-ras, Ki-ras and N-ras genes [1,2,4]. The ma-
jority of C to T transitions occurred at dipyrirnidine sites, and espe-
cially a double-base change, such as CC to TT, is considered to be 
specific to ultraviolet (UV) light [5-8]. SCC may develop from 
solar keratosis (SK), which is a result of long-term exposure to 
sunlight. 
The abnormal accumulation of p53 protein was found by the 
immunohistochemical staining with antibody to p53 protein in the 
nuclei of SK [9 - 11]. Immunohistochemical detection of p53 pro-
tein, however, may not indicate the presence of p53 gene mutations 
[4). To clarify the presence of p53 gene alteration in SK, we used a 
combination of the polymerase chain reaction and single-strand 
conformation polymorphism (PCR-SSCP) analysis [12] and direct 
DNA sequencing analysis. A correlation between alteration of the 
p53 gene and accumulation of p53 protein was also analyzed. 
MATERIALS AND METHODS 
Sample Fresh specimens of 27 SK were excised from 25 patients between 
June 1991 and December 1992 under the collaboration of Department of 
Dermatology of the National Cancer Center Hospital; Saitama Medical 
School; School of Medicine, Yokohama City University; School of Medi-
cine, Kyushu University; and the School of Medicine, Kagoshima Univer-
sity. Surgical specimens were either fixed with the AMeX (acetone-methyl 
benzoate-xylene and paraffin embedding) method [13] of embedded in 
OCT compound (TISSUE-TEK, Miles) to perfonn tissue sections, and were 
subsequently sent to the Epidemiology Division, National Cancer Center 
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to A and T to C nucleotide changes. p53 protein was 
detected immunohistochemically in the nuclei of six 
of27 cases (22%) of solar keratosis. Nuclear staining for 
p53 protein was only significantly correlated with the 
presence of missense mutation of p53 gene (p < 0.01). 
Aberrations of the p53 gene in solar keratosis may be a 
marker to predict early cancerous lesions. Key words: 
UV /carcinogenesis/PCR-SSCP /immunohistochemistry. ] 
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Research Institute, and stored at -BO·C until use. Genomic DNA extrac-
tions were performed on AMeX sections and frozen sections (50}lm in 
thickness) using the proteinase K-phenol-chloroform extraction method as 
described by Goelz et al [14]. Five normal parts of the biopsied skin with SK 
and five skin tissues from the non-sun-exposed areas were used for control 
specimens. 
PCR-SSCP Analysis DNA samples (0.1 }lg) were subjected to a polym-
erase chain reaction (PCR) using two appropriate oligonucleotides as 
primers [15]. The oligonucleotide primers for PCR amplification of all p53 
exons (exon 2 to 11) were designed as described previously [16]. The PCR 
was carried out in 17 }ll solution containing 1.25 mM dA TP, 1.25 mM 
dGTP, 1.25 mM dCTP, 1.25 mM dTTP, 0.75-1.0 mM MgCI2' 10}lM 
primers, 0.1 }lg of sample DNA, 0.2}l1 of [a_32p] dCTP (3000 }lCi/mmol, 
10 mCi/}lI, Amersham), 0.5 unit ofTaq DNA polymerase (Perkin-Elmer 
Cetus, Norwalk, CAl in 10 mM Tris-HCI, pH B.3, containing 0.1 % gelatin, 
and 12}l1 mineral oil. The samples were subjected to 30 cycles at 94·C for 30 
seconds, 55·C for 30 seconds, and 72·C for 60 seconds, on a DNA thennal 
cycler (Perkin-Elmer Cetus). On another occasion, the 5' -ends of these 
primers were labeled by the polynucleotide kinase reaction with [y_32P]A TP 
as described previously [17]. 
The PCR mixture (5 }ll) was heated at BO·C with 45}l1 offormamide dye 
mixture (95% formamide dye, 20 mM ethylenediaminetetraacetic acid, 
0.05% xylene cyanol, 0.05% bromphenol blue), and then 1 }ll of the prepa-
ration was applied to 5% polyacrylamide gel containing 45 mM Tris-borate 
(PH B.3) and 4 mM ethylenediaminetetraacetic acid. Glycerol (5%) was 
added for better separation of bands. Electrophoresis was perfonned at 30 W 
for 2 to 4 h with cooling by a fan. The gel was dried on filter paper and 
exposed to X-ray film at - 80·C for 4 to 12 h using an intensifying screen. 
The PCR-SSCP analysis was repeated 2-4 times to confirm the same mo-
bility shift pattern. 
Direct DNA Sequencing DNA fragments showing repeatedly the same 
mobility shift pattern by PCR-SSCP analysis were eluted from polyacrylam-
ide gel as described previously [18], and were amplified by 30 cycles of the 
symmetric PCR under the same conditions as described earlier. The reaction 
mixture was diluted and deionized in a Centricon 30 microconcentrator 
(Amicon, Danvers, MA). After the amplified DNAs had been annealed with 
the 5' -labeled primers, nucleotide sequences were determined using a dou-
ble-strand DNA Cycle Sequencing System (Gibco BRL). 
Immunohistochemistry Immunohistochemical staining was performed 
on AMeX sections and frozen sections using an avidin-biotinylperoxidase 
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Table I. Aberrations of p53 Gene and p53 Protein in Solar Keratosis 
Tumor Immunohistochemical Aberration 
p53 alteration 
Case Histologic Site Staining of p53 Gene Exon Codon Base Change' Amino Acid 
SKS Atrophic Cheek + 
SK40 Bowenoid Head + 
SK19 Bowenoid Cheek + 
SK18 Atrophic Cheek + 
SK33 Bowenoid Nose 
SK25 Atrophic Temple 
SK7 Bowenoid Chest + 
SK27 Bowenoid Temple 
SK8 Bowenoid Chest + 
SK4 Bowenoid Cheek 
• Asterisks, mutation at CpG methylation site; underline, deleted site. 
complex method as described by Hiyoshi et 01 [19]. The monoclonal anti-
bodies to p53 protein, pAb 1801, and D07 were obtained from Oncogene 
Science Inc. and Novocastra Laboratories Ltd., respectively. As positive con-
trols, we used AMeX-fixed colon cancer tissuc sections. Negative controls 
were tissue sections that were incubated without the primary antibody. 
RESULTS 
Aberrations of the p53 Gene in SK The number of cases show-
ing the immunohistochemical accumulation of the pS3 protein in 
the nuclei and/or an aberration of the pS3 gene by PCR-SSCP 
analysis was 10 of 27 SK (Table I and Fig ta, b). In PCR-SSCP 
analysis, DNA extracted from non-sun-exposed normal skin (five 
normal part of biopsied SK and five from non-sun-exposed area) 
did not show any abnormal band mobility. An aberration of the pS3 
a b 
Figure·I. Mobility sift of DNA allele from solar keratosis. PCR-SSCP 
analysis of DNA fragments obtaincd through PCR by the probes of p53 
gene. Result for exons 7 and 10 are shown in a and b, respectively. Aberra-
tions of p53 gene induce a confonnational change and results in a variant 
pattern of migration (arrollls) . Comparative migration of the wild-type p53 
gene fragment (indicated as normal) is present in each mutated sample. 
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4 109 TIC-TCC: T-C Phe-Ser 
4 110 cC*GT -cTGT : C-T Arg-Cys 
6 194 CTT ATCCG-CTG 5 base deletions 
6 215 AGT-AGG :T-G Ser-Arg 
7 248 cC*GG-cTGG: C-T Arg-Trp 
8 271 GAGGTGC-GGC 4 base deletions 
8 278 tCCT-tACT:C-A Pro-Thr 
10 342 cC*GA-cTGA: C-T Arg-Stop 
gene was present in eight of 27 SK (30%). Histologically, the bo-
wenoid type was found to have mutations in a higher proportion of 
the cases, six of 9 (67%), and the atrophic type was found less 
frequently, in two of 11 cases (18%). Mutation was not detected in 
the five cases with a hypertrophic type lesion in the two cases with 
an acantholytic type lesion. The mutations were detected in exons 
4, 6, 7, 8, and 10. Six of eight mutations were single-nucleotide 
missense mutations (Fig 2a) . Cases SK4, SK27, and SK33 showed 
the pS3 gene alteration, which lost the pS3 protein production 
because of nonsense mutation to stop codon, or by several base 
deletion (Fig 2b and Table I). Base substitutions were three C to T 
and one T to C transitions, and one each T to G and C to A transver-
siollS. Dipyrimidine sites were involved in five cases. Three C to T 
substitutions occurred on the CpG methylation site (Table I). 
Immunohistochemical Analysis of the p53 Protein pS3 pro-
tein was stained in the nuclei of six of 27 SK (Table I and Fig 3). 
Degree of positive nuclear staining varied by cases, but mostly more 
than half nuclei were stained. It was not detected in the neighboring 
normal epidermal cells and stromal cells. 
Relationship Between p53 Gene Mutations and Nuclear Ac-
cumulation of p53 Protein The nuclear staining for pS3 pro-
tein and the presence of the pS3 gene alterations were not statisti-
cally associated (p < 0.08, Fisher's exact test). Association between 
the above two, however, became significant when only the missense 
mutation was accounted (p < 0.01, Fisher's exact test) (Table U). 
In SK2S, nuclear staining of the pS3 protein was negative, although 
the mutation from T to G was detected. This mutation was different 
from the common UV-specific substitution at dipyrirnidine site. 
The other three cases (SK33, SK27, and SK4) that were negative for 
nuclear staining had genetic changes to stop codon type (Table I). 
In SKS and SK40, aberrations of the pS3 gene were not detected 
despite the positive nuclear staining of pS3 protein (Table I). 
DISCUSSION 
We formerly reported the usefulness of immunohistochemical 
staining with anti-pS3 protein antibody [11]. An accumulation of 
the pS3 protein in the nuclei usually suggested the presence of a 
mutation in the gene, although pS3 accumulation was also observed 
shortly after UVB irradiation [20]. Campbell et of [21] reported that 
pS3 protein accumulated in the normal human skin as early as 24 h 
after UVB or UVC irradiation. In acute irradiation, pS3 protein 
may accumulate by direct binding to the damaged DNA or as a 
result of binding to heat-shock protein [22] . The gene sequence 
analysis in this study revealed that two cases had no mutation at all in 
the pS3 exons regardless of the positive pS3 staining. 
Four of six cases (67%) showed a significant coincidence between 
positive staining of pS3 protein and gene alteration. UV light may 
produce specific mutations, leaving a "signature" in the DNA. Mu-
tations due to direct absorption of UV light by DNA are predomi-
nantly C to T transitions at dipyrimidine sites, including CC to IT 
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Figure 2. Point mutation in p53 gene. Nucleotide sequence analysis of 
amplified fragments of p53 gene. Point-mutation at codon 248 (antisense G 
to A, arrows) in SK 7 and at codon 342 (antisense, G to A, arrows) in SK 5 
tumor tissues were shown, respectively. Comparative sequence of the wild-
type DNAs (indicated as WT) is i"?c1uded in each mutated sample. a) Se-
quence ofDNAs around codon 248 10 exon 7 from the tumor tissues ofSK 7 
and b) sequence of DNAs around codon 342 in exon 10 from the tumo; 
tissue of SKS. 
double-base mutations [5 -8]. The appearance of C to T transitions 
exclusively at dipyrimidine site.s is also frequent by UV exposure. 
C~1a.nce ,:"ould dIctate that one m four would occur at a monopyri-
midme slte [1]. Frequent C to T pattern of mutation was also re-
ported bX .~ampbell et ~f [2~] i~ Bowen's disease. They suggested 
that the mltlal mutageruc lesIOn m the p53 gene in these lesions was 
dipyrimidine photoproducts induc~d b~ UV irradiation [23]. 
Th~ spectrum of observed mutations m the case of solar keratosis 
was dIfferent from those observed by Brash et af [1] in SCC from 
sun-exposed skin. We found that five of eight cases (62.5%) of SK 
contained a mutation spectrum at dipyrimidine site specific for UV. 
Other uncommon UV specific mutations were one each of C to A 
and T to C nucleotide changes. These changes, however, were also 
found in the experimental UV irradiation [7,8]. At least CC or GG 
sequence was involved in the two short deletion sites in our study 
(Table I). Moles et al reported the similar change in BCC [4]. 
Methylation of CpGs in normal tissues Ulay increase the probability 
of mutations at such sites because of the ability of 5-methylcytosine 
to undergo deamination and result in thymine [24]. The p53 gene 
mutation in BCC at CG dinucleotides suggests that the particular 
mutation may be due to the 1 06-fold acceleration of cytosine deami-
nation rate by cyclobutane dimers, occurring at 5-methylcytosine 
[25]. Nearly one third of the 280 human p53 tumor mutations were 
transitions at hot sporcodons with CpG sites (codons 175, 196,213, 
248, 273, ~nd 282) .in human cancer of internal organs [26]' In 
recent studIes, mutations at codon 248 were frequently observed in 
BCC and SCC by UV exposure [1,3,25] . In our series, only one of 
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Figure 3. Accumulation of p53 protein in the nuclei. Immunohisto-
chemical staining f?r p53 .protein in SK. Accumulation of p53 protein is 
noted 10 the nucleI of epIdermal cel ls. Stromal cells are negative. ABC 
immunostain for pS3 protein. Bar, 100/lm. 
eight (12.5%) SK cases showed transitions at hot spot codon 248 in 
p5~ ~ene. Four cases were negative for p53 immunohistochemical 
stammg, although p53 gene aberrations were present. These were 
attri~uted t~ nonsense mutation to the stop codon or several base 
deletions. ZIegler et af [25] reported that the arginine changed to a 
st~p codon (c?don 342) in p53 gene in BCe. In the arginine codon 
bemg CGA m the p53 gene, these changes are likely to appear 
because of the ability of 5-methylcytosine to undergo deamination. 
Sequencing of the p53 gene in mammals, amphibians, birds, and 
fish has revealed five highly conserved domains, four of which fall 
with~ e:,ons 5 t~ough 8 [26]. Ninety-eight percent of 280 base 
substItutIOn mutatIOns analyzed fell within a 600-base pair region of 
the p53 gene product (codons 110 to 307) [27]. In epithelial skin 
tuI?ors, . h~wever, about 30% of the aberrations of the p53 gene 
eXIsts witlun exons 4, 9, and 10 [1,25]. It is better to examine entire 
domains of p53 gene for characterization of the UVB effects on this 
gene. 
The use of immunohistochemical staining is a convenient and a 
useful tool for screening the p53 missense mutations. Combination 
of both i~unohistochemical staining and PCR-SSCP analysis, 
however, IS neces~ary because the non-production of p53 protein 
d~e to ge~e mutatIOn to stop codon was not negligible in p53 pro-
teIn negative cases. 
In the study of p53 knockout mice, Kemp et af [28] reported that 
lack.of p53 not only increases the rate of benign to malignant con-
verSIOn, but also seems to drive further changes toward loss of dif-
f~rentiation with increasing malignancy. Furthermore, they inves-
tigated that other genetic alterations, which may be facilitated by 
muta~t ras acting synergistically with lack of p53 gene, were re-
spo~slble for ~riving malignant progression [28] . In our study, SK 
havmg alteration of p53 gene may possess ability to transform into 
SCC. In our preliminary work, by using the same SK sample in this 
s~d~, we found a point mutation of Ha-ras without any p53 muta-
tion m one case (unpublished data). 
A follow-up study of SK patients with p53 alteration is necessary 
Table II. Association of p53 Gene Missense Mutation with 
Nuclear Staining of p53 Protein in Solar Keratosis 
Nuclear staining 
Positive 
Negative 
With p53 
Gene Mutation 
4 (67%) 
1 (5%) 
Without p53 
Gene Mutation 
2 (33%) 
17 (94%) p < 0.01 
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to confirm the relationship between the p53 alterations in prema-
lignant skin lesions and the progression to Scc. 
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